Nova Patents
IL261602A

Antibodies to cd40 with enhanced agonist activity

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority and filed
  2. Published
  3. Today

30 members in 13 offices

This recordMember, by publication date3 more offices are in the list below

Members30

Family members, oldest first
DocumentOfficeKind
US2017253659A1United States of AmericaA1
CA3016534A1CanadaA1
WO2017151176A1World Intellectual Property Organization (WIPO)A1
AU2016394956A1AustraliaA1
KR20180114223ARepublic of KoreaA
SG11201807677YASingaporeA
IL261602AThis recordIsraelA
CN109071655AChinaA
EP3423489A1European Patent Office (EPO)A1
BR112018067802A2BrazilA2
EA201891925A1Eurasian Patent Organization (EAPO)A1
MX2018010672AMexicoA
US10894835B2United States of AmericaB2
US2021139598A1United States of AmericaA1
CN109071655BChinaB
CN116063494AChinaA
US11760805B2United States of AmericaB2
IL307425AIsraelA
US2024026021A1United States of AmericaA1
IL261602B1IsraelB1
AU2016394956B2AustraliaB2
IL261602B2IsraelB2
AU2024202924A1AustraliaA1
EP4406550A2European Patent Office (EPO)A2
EP3423489B1European Patent Office (EPO)B1
EP4406550A3European Patent Office (EPO)A3
ES2985566T3SpainT3
IL307425B1IsraelB1
IL307425B2IsraelB2
US12577315B2United States of AmericaB2